ED
SI

Exane Derivatives’s Silvergate Capital Corporation SI Stock Holding History

Exane Derivatives’s Portfolio SI Stock Details SI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.12K Sell
21
-1,304
-98% -$122K ﹤0.01% 495
2022
Q1 		$199K Sell
1,325
-151
-10% -$18.7K 0.06% 335
2021
Q4 		$219K Buy
+1,476
New +$252K 0.05% 320

Other funds holding SI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $150M AUM 32.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Exane Derivatives's SI Position: Q2 2022 in Review

Exane Derivatives reduced its Silvergate Capital Corporation (SI) stake by 98% in Q2 2022, selling an estimated $122K and leaving 21 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

Exane Derivatives first reported a position in SI in Q4 2021 and has held it in 3 quarters since. The position peaked at $219K in Q4 2021. 257 funds tracked by Wall St. Rank hold SI as of Q2 2022.

  • Exane Derivatives held 21 shares of Silvergate Capital Corporation worth $1.12K as of Q2 2022.
  • Exane Derivatives sold 1,304 Silvergate Capital Corporation shares in Q2 2022, an estimated $122K.
  • Silvergate Capital Corporation made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #495 holding.
  • Exane Derivatives first reported a position in Silvergate Capital Corporation in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's Silvergate Capital Corporation position peaked at $219K in Q4 2021.
  • 257 funds tracked by Wall St. Rank held Silvergate Capital Corporation as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.